Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 18;12:113. doi: 10.1186/s13048-019-0592-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — S100A10 was upregulated in ovarian cancer tissues with carboplatin resistance, and high S100A10 expression predicted poor prognosis. (a) The expression of S100A10 protein in tumor tissues from patients with carboplatin-sensitive or carboplatin-resistant ovarian cancer by immunohistochemistry analysis and representative staining images are shown. Representative images are shown at × 100 (upper panels) or × 400 (lower panels) magnification. (b) Estimation of progression-free survival and overall survival curves by Kaplan-Meier analysis with log-rank test in 138 ovarian cancer patients according to S100A10 expression